Integrated transcriptomic, imaging, and molecular analyses identify disease-associated signatures and therapeutic response biomarkers.

Biomarkers play a critical role in understanding disease biology, monitoring disease progression, and evaluating therapeutic efficacy. Using advanced human cell and organoid platforms, Nocteva enables the identification and validation of molecular, cellular, and functional biomarkers in physiologically relevant systems.
Our integrated approach combines disease-relevant models with high-content phenotyping and multi-omics analysis to support biomarker discovery from early research through translational development.